5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Poly Medicure Ltd.

•
polymedicure.comBSE: 531768NSE: POLYMED
Market Cap₹ 17,473 Cr.
Current Price
High / Low₹ 2,108 / 1,182
Stock P/E52.0
Book Value₹ 309
Price to Book3.96
Dividend Yield0.20 %
ROCE14.9 %
ROE11.6 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2023 • Medical Devices: 100.0%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 21.0% CAGR over last 5 years
  • Company is almost debt free
  • Company has delivered good sales growth of 17.3% CAGR over last 5 years
  • Company comfortably covers its interest (29.9x coverage)
  • Working capital cycle has improved - days down from 346 to 266
  • Company has a consistent dividend-paying track record

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • A large part of profit comes from other income (27.9% of PBT)
  • Promoter holding has decreased over last 2 years: -3.6pp
  • Total debt has risen sharply - up 46.3% year on year
  • Though reporting repeated profits, the company pays out little dividend (10.6%)
  • Expensive relative to growth - PEG of 2.2

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareMedical Equipment/Supplies/Accessories
Part ofNIFTY TOTAL MKTNIFTY SML250 Q50NIFTY 500NIFTY SMLCAP 250
S.No.Name
1.LENSKART694.05184.20120716.540.002284.303634.3527141.801332.6912.5521.70
2.POLYMED1723.8055.4517472.690.2085.27-8.39525.3830.3014.0524.11
3.MOLBIO1258.1087.0314498.340.00527.44—4083.76—19.7924.63
4.3BBLACKBIO1472.1022.751263.450.348.98-28.9933.4950.5926.0325.45
5.LAXMIDENTL200.4035.701102.790.0010.3223.8374.7016.1324.9620.26
6.GKB66.1310.2833.330.001.85387.9933.042.268.827.97
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
306320321361367402411421384417419443431
220237236264266290295305282305307322341
Operating Profit8583849710111311511610211111212190
OPM %27.85%25.82%26.30%26.96%27.51%28.02%28.10%27.60%26.46%26.70%26.80%27.33%20.87%
13131716172722244134231529
Interest2233333233444
Depreciation15151616192021212324252626
Profit before Tax8178829496117113116117118106107119
Tax %25.15%24.06%25.13%24.94%24.74%25.41%24.91%25.61%24.89%24.54%26.06%24.51%25.72%
Net Profit61596171728785878889788188
6.316.176.417.357.538.998.488.408.688.797.737.958.69

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
4395085876467478791,0681,3071,6021,6621,710
3453874534845376658029561,1541,2191,275
Operating Profit94122134162210214266351448443435
OPM %21.41%23.90%22.84%25.11%28.15%24.32%24.94%26.86%27.97%26.66%25.42%
141416191939365890118100
Interest81113201051013141615
Depreciation23283639465356628198101
Profit before Tax7696100122173195237335443448449
Tax %26.31%27.15%34.04%24.14%25.30%25.01%24.40%24.83%25.19%24.99%25.20%
Net Profit56706692130146179252331336336
EPS6.377.957.5110.4614.5315.2218.6526.2332.7033.15—
Dividend Payout %39.25%25.14%26.62%19.10%18.51%16.42%16.08%11.44%10.70%10.56%—

COMPOUNDED SALES GROWTH

10 Years:
15%
5 Years:
17%
3 Years:
16%

COMPOUNDED PROFIT GROWTH

10 Years:
22%
5 Years:
21%
3 Years:
23%

STOCK PRICE CAGR

10 Years:
25%
5 Years:
12%
3 Years:
8%
1 Year:
-10%

RETURN ON EQUITY

10 Years:
18%
5 Years:
15%
3 Years:
15%
Last Year:
12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2017

Mar 24

1:1

Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 06, 2017, inter alia, to consider the following: 1. To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on December 31, 2016. 2. To consider declaration of 2nd interim dividend, to the Equity Shareholders of the Company for the current financial year 2016-17. 3. To consider the issue of Bonus Shares, subject to approval of shareholdeis to be obtained in this behalf.

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital44444444484848485151
2252903353859051,0271,1841,4072,6912,995
103134156196129113139152171248
Trade Payables41435060567878897785
364375869367147199238262
Total Liabilities4495556617721,2311,3341,5961,8943,2283,641
2002562693243854475978311,0471,217
Capital Work in Progress1210917153773678990
61842583853841812211,1261,243
586974101109150183193250281
0000000259340442
Cash & Bank2220532227817113714343
151182213250310307391187232324
Total Assets4495556617721,2311,3341,5961,8943,2283,641

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
7399141162161173255256230245
Cash from Investing-54-87-104-106-434-89-189-237-1,184-268
Cash from Financing-114-10-22319-40-8-1795328
03-1-11-2-02-25

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
66.0362.5662.4462.4462.4462.4262.4262.4262.42
9.9111.8612.3111.4411.419.779.405.925.56
9.3412.3311.6611.9611.7213.5313.8415.6016.08
Government0.000.000.000.000.000.000.000.000.00
14.7213.2413.5714.1514.4414.2714.3416.0815.94

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-07
Shareholders meeting

2026-09-07 - Poly Medicure Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 05, 2026. Further, the company has informed the Exchange regarding voting results.

2026-09-05
Shareholders meeting

2026-09-05 - Poly Medicure Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 05, 2026

2026-09-02
General Updates

2026-09-02 - Poly Medicure Limited has informed the Exchange about General Updates

2026-08-25
General Updates

2026-08-25 - POLYMED: Intimation On Rescheduling Of Investor/Analyst Meet

2026-08-22
General Updates

2026-08-22 - Intimation for the schedule of Investors/Analyst Call/ Meet.

2026-08-20
General Updates

2026-08-20 - Investor Call Scheedule to be held on 20th August, 2026 is Cancelled

2026-08-17
General Updates

2026-08-17 - Poly Medicure Limited has informed the Exchange about the schedule of Investors/Analysts Call/Meet

2026-08-15
Copy of Newspaper Publication

2026-08-15 - Poly Medicure Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-14
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-14 - Poly Medicure Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for POLYMED

Loading news…

🤖

AI Stock Analyst

Poly Medicure Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login